Encontrados 2 documentos, a visualizar página 1 de 1
Enhancing primary prevention: the incremental predictive value of high-sensitiv...
Andraz, S.; Pereira, J. Massa; Costa, H.; Espirito Santo, M.; Hamann, L.; Fernandes, R.; Bispo, J.; Carvalho, D.; Bento, D.; Azevedo, P.; Mimoso, J.Atherosclerotic cardiovascular disease (ASCVD) is a global health challenge, prompting widespread use of conventional risk assessment tools (SCORE2 in Europe and the ASCVD Risk calculator in the United States) to guide preventive strategies. Emerging evidence indicates that high-sensitivity cardiac troponin (hsTn) may refine risk stratification.
Outcomes of diabetic patients with acute coronary syndromes treated with aspiri...
Costa, H.; Espirito Santo, M.; Fernandes, R.; Carvalho, D.; Bispo, J.; Guedes, J.; Azevedo, P.; Vinhas, H.; Mimoso, J.; Jesus, I.The use of aspirin in primary prevention (PP) remains a matter of international debate. In type 2 diabetes mellitus (DM2) patients with high/very high cardiovascular (CV) risk, low dose aspirin may be considered for PP (class IIb, evidence level A) in european guidelines in the absence of hemorrhagic contraindication.